Cargando…
LHX2 promotes malignancy and inhibits autophagy via mTOR in osteosarcoma and is negatively regulated by miR-129-5p
The transcript factor LHX2 is dysregulated in many cancers but its role in osteosarcoma (OS) remains unclear. In this study, we confirm that LHX2 is up-regulated in osteosarcoma, and that its silencing inhibits OS malignancy and induces autophagy via mTOR signaling. We further demonstrate that miR-1...
Autores principales: | Song, Honghai, Liu, Jiaming, Wu, Xin, Zhou, Yang, Chen, Xuanyin, Chen, Jiangwei, Deng, Keyu, Mao, Chunxia, Huang, Shanhu, Liu, Zhili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874432/ https://www.ncbi.nlm.nih.gov/pubmed/31724536 http://dx.doi.org/10.18632/aging.102427 |
Ejemplares similares
-
iTRAQ‐based proteomic analysis of the molecular mechanisms and downstream effects of fatty acid synthase in osteosarcoma cells
por: Fu, Dahua, et al.
Publicado: (2021) -
Estrogen receptor β induces autophagy of osteosarcoma through the mTOR signaling pathway
por: Yang, Zhengming, et al.
Publicado: (2020) -
mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016) -
mTOR, autophagy, and reprogramming
por: Tang, Bor Luen
Publicado: (2014) -
Aurora-B knockdown inhibits osteosarcoma metastasis by inducing autophagy via the mTOR/ULK1 pathway
por: Wu, Xin, et al.
Publicado: (2020)